Fresh analysis reveals that individuals who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide may regain lost weight at a significantly accelerated pace than those who halt conventional lifestyle plans.
Findings released in a leading medical journal shows that while overweight individuals frequently drop a large proportion of their total mass while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month once they quit.
"People purchasing such treatments should be cognizant of the danger of fast rebound weight gain when the therapy concludes," stated researcher Dr. Susan Jebb.
This pace of recovery implies a reversion to starting weight in about 18 months.
Weighing Approaches
The analysis, which reviewed dozens of trials involving over 9,000 of participants, compared the results of GLP-1 agonists with older methods.
The team point out that individuals who shed pounds through dieting typically see a more gradual creep back—perhaps 100 grams monthly—post-intervention.
The Reason for the Rapid Regain
Nutrition scientists believe the way of the jabs is key to understanding the heightened weight return.
GLP-1 drugs copy a natural hormone called GLP-1, which controls feelings of fullness.
"Artificially providing GLP-1 levels far above than the body's typical production could lead to the system to generate a reduced amount of its own natural GLP-1, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this hormone supplement results in appetite is unsuppressed, making overeating far more likely."
A Lifelong Condition?
The NHS recommend the jabs for people with obesity-related health risks, alongside recommended lifestyle changes.
Many experts say that, due to the high risk of weight regain, the treatment might need to be ongoing.
This perspective is echoed by pharmaceutical companies, who state that the findings "highlight the chronic nature of obesity," comparing it to managing diseases like hypertension.
Patient Accounts
Individuals who have stopped the medication report a powerful resurgence of hunger.
"It was like a trigger that goes on and you become starving," said a patient.
The struggle is compounded if individuals have not established lasting lifestyle or habit modifications during treatment.
Widespread Interest
Survey data indicate that a significant number of adults in the UK have tried these injections in the past year, with desire continuing to grow.
- Use is greater among females than males.
- The middle-aged age group shows the greatest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
Finally, experts emphasize that while the jabs are effective tools for shedding pounds, they are not a permanent solution and maintained weight loss relies on combined behavioural changes.
